Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Drug Delivery
|
June 11, 2013
A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers
Sahar Hosseinzadeh, Azam Bolhassani, Sima Rafati, et al.
Experimental Parasitology
|
December 29, 2010
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies
Azam Bolhassani, Tahereh Taheri, Yasaman Taslimi, et al.
Parasite Immunology
|
December 8, 2019
The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica
Shima Nahidi, Elham Gholami, Yasaman Taslimi, et al.
Experimental Parasitology
|
February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model
Azam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Plos Neglected Tropical Diseases
|
July 15, 2017
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
Alireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, et al.
Experimental Parasitology
|
July 26, 2003
Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis
Sima Rafati, Alireza Nakhaee, Tahere Taheri, et al.
Vaccine
|
April 10, 2007
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
Majid Golkar, Mohammad-Ali Shokrgozar, Sima Rafati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 3, 2011
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases
|
July 19, 2011
C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c mice
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases
|
July 14, 2017
A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
Yasaman Taslimi, Pardis Sadeghipour, Sima Habibzadeh, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Drug Delivery
|
June 11, 2013
A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers
Sahar Hosseinzadeh, Azam Bolhassani, Sima Rafati, et al.
Experimental Parasitology
|
December 29, 2010
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies
Azam Bolhassani, Tahereh Taheri, Yasaman Taslimi, et al.
Parasite Immunology
|
December 8, 2019
The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica
Shima Nahidi, Elham Gholami, Yasaman Taslimi, et al.
Experimental Parasitology
|
February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model
Azam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Plos Neglected Tropical Diseases
|
July 15, 2017
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
Alireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, et al.
Experimental Parasitology
|
July 26, 2003
Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis
Sima Rafati, Alireza Nakhaee, Tahere Taheri, et al.
Vaccine
|
April 10, 2007
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
Majid Golkar, Mohammad-Ali Shokrgozar, Sima Rafati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 3, 2011
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases
|
July 19, 2011
C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c mice
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases
|
July 14, 2017
A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
Yasaman Taslimi, Pardis Sadeghipour, Sima Habibzadeh, et al.
Page
of 14